Christoph R Meier (C R Meier)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Venues

The British journal of dermatology

Pharmacoepidemiology and drug safety

Expert opinion on drug safety

Journal of clinical pharmacy and therapeutics

Harvard School of Public Health (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Harvard School of Public Health Aug 01 1995 - Aug 01 1997

United States

MSC :: Pharmacoepidemiology

Universität Basel Medizinische Fakultät Mar 01 1988 - Jun 01 1990

Switzerland

PHD :: Clinical Pharmacology and Toxicology

Universität Basel Sep 01 1982 - Oct 01 1987

Switzerland

MSC :: Pharmaceutical Sciences

Publications

Tamino Zappalà, Jesper Hallas, Carola A Huber, Daphne Reinau, Christoph R Meier, Julia Spoendlin
Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Association With the Swissmedic Safety Alert Regarding Non-melanoma Skin Cancer: An Interrupted Time-Series Analysis Using Swiss Claims Data. Pharmacoepidemiology and drug safety 33 (9) (2024)
Aylin N Satir, Miriam Pfiffner, Christoph R Meier, Angela Caduff Good
Prescribing errors in children: what is the impact of a computerized physician order entry? European journal of pediatrics (2023)
Aylin N Satir, Miriam Pfiffner, Christoph R Meier, Angela Caduff Good
Prescribing Patterns in Pediatric General Wards and Their Association with Prescribing Errors: A Retrospective Observational Study. Drugs - real world outcomes (2023)
Delia Bornand, Daphne Reinau, Susan S Jick, Christoph R Meier
β-Blockers and the Risk of Depression: A Matched Case-Control Study. Drug safety 45 (2) (2022)
Nina L Wittwer, Christoph R Meier, Carola A Huber, Henriette E Meyer Zu Schwabedissen, Allemann Samuel, Cornelia Schneider
Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database. Pharmacogenomics and personalized medicine 15 (2022)
R Schneider, D Reinau, S Stoffel, S S Jick, Christoph R Meier, J Spoendlin
Risk of skin cancer in new users of thiazides and thiazide-like diuretics: a cohort study using an active comparator group. The British journal of dermatology 185 (2) (2021)
Theresa Burkard, Marlene Rauch, Susan S Jick, Christoph R Meier
Validity of bariatric surgery codes in the UK Clinical Practice Research Datalink (CPRD) GOLD compared with Hospital Episodes Statistics. Pharmacoepidemiology and drug safety 30 (7) (2021)
Carole A Marxer, Stephan J Rüegg, Marlene S Rauch, Alice Panchaud, Christoph R Meier, Julia Spoendlin
A review of the evidence on the risk of congenital malformations and neurodevelopmental disorders in association with antiseizure medications during pregnancy. Expert opinion on drug safety 20 (12) (2021)
Claudia Becker, Matthias E Schwenkglenks, Mathias Frueh, Oliver Reich, Christoph R Meier
Use of selective serotonin reuptake inhibitors, other antidepressant medication, and risk of cataract: a case-control study based on Swiss claims data. European journal of clinical pharmacology 76 (9) (2020)
Daphne Reinau, Chiara Furrer, Dominik Stämpfli, Delia Bornand, Christoph R Meier
Evaluation of drug-related problems and subsequent clinical pharmacists' interventions at a Swiss university hospital. Journal of clinical pharmacy and therapeutics 44 (6) (2019)
Nadja A Stohler, Daphne Reinau, Susan S Jick, Daniel Bodmer, Christoph R Meier
A study on the epidemiology of tinnitus in the United Kingdom. Clinical epidemiology 11 (2019)
Christoph R Meier
Rosacea, inflammatory bowel disease and the value of big data and of epidemiological studies. The British journal of dermatology 176 (1) (2017)

Christoph R Meier.css-eqlu8i{font-size:small;padding-left:4px;} (C R Meier)

Publication Activity (10 Years)

Top Topics

Top Venues

Christoph R Meier (C R Meier)